{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_001130553.3:c.1309T>A",
          "cDNA Change": {
            "transcript": "NM_001130553.3",
            "ref": "T",
            "alt": "A",
            "position": "1309"
          },
          "Protein Change": {
            "ref": "Trp",
            "alt": "Ter",
            "position": "437"
          },
          "Description in input context": "homozygous W437X nonsense mutation in the PINK1 gene"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005315"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial respiration analysis (Seahorse XF)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Patient-derived fibroblasts and control fibroblasts",
        "Description": "Mitochondrial respiration was measured in fibroblasts from patients with the PINK1 W437X mutation and healthy controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130553.3:c.1309T>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Fibroblasts with the PINK1 W437X mutation exhibited significantly reduced mitochondrial respiration (OCR) and increased mitochondrial membrane potential compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed with fibroblasts from different patients."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experiment was repeated three times using the Seahorse XF analyzer."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control fibroblasts from healthy individuals were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated fibroblasts without exogenous compounds were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare respiration rates between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "OCR values within 10% of control fibroblasts",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "OCR values reduced by >20% compared to controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}